Coproporfiria hereditaria. Estudios bioquimicos en 7 pacientes sintomaticos y familiares

Seven patients with hereditary coproporphyria (HCP) and 14 relatives from six families have been studied. Three of seven patients (43%) exhibited cutaneous signs, hyperpigmentation, photosensitivity and all of them presented acute neurovisceral attacks. Biochemical parameters of the HCP patients sho...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stella, A.M., Melito, V.E., Melito, V.A., Noriega, G., Muramatsu, H., Tomassi, L., Magnin, P.H., Del Batlle, A.M.C.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_03252787_v79_n3_p144_Stella
Aporte de:
id todo:paper_03252787_v79_n3_p144_Stella
record_format dspace
spelling todo:paper_03252787_v79_n3_p144_Stella2023-10-03T15:23:25Z Coproporfiria hereditaria. Estudios bioquimicos en 7 pacientes sintomaticos y familiares Stella, A.M. Melito, V.E. Melito, V.A. Noriega, G. Muramatsu, H. Tomassi, L. Magnin, P.H. Del Batlle, A.M.C. aminolevulinic acid coproporphyrin folic acid fructose glucose porphobilinogen porphyrin s adenosylmethionine vitamin b complex adult article carbohydrate intake clinical article differential diagnosis familial disease female human hyperpigmentation male oral drug administration photosensitivity porphyria porphyria cutanea tarda porphyria variegata relative remission Seven patients with hereditary coproporphyria (HCP) and 14 relatives from six families have been studied. Three of seven patients (43%) exhibited cutaneous signs, hyperpigmentation, photosensitivity and all of them presented acute neurovisceral attacks. Biochemical parameters of the HCP patients showed an increase of 5-aminolevulinic acid (ALA) (3.9 - 14.1 mg/24h.), porphobilinogen (PEG) (6.5 - 47.9 mg/24h) and total porphyrins (645 - 31129 μg/ 24h)in urine, which diminished when they reached remission (ALA: 0.2 - 5.3 mg/24hs; PBG: 0.8 -25.2 mg/24h, total porphyrins: 112 - 952 μg/24h, Normal Values: ALA: 2-4 mg/24h, PBG: 1-2 mg/ 24h, total porphyrins: 20 - 250 μg/24h). The fecal porphyrins were also increased during the acute phase (316 - 50,056 μg/g wet) and reduced in remission (165 -1600 μg/g wet). The pattern of urinary porphyrins showed a high concentration of coproporphyrin, and emission wavelengt at 618 nm of the plasma porphyrins allowed to distinguish this porphyria from variegate prophyria (VP). Treatment of the acute attack of HCP was similar to that applied to acute intermittent porphyria or VP: carbohydrates (acute attack: 330 - 500 g/day; light attacks: 20 - 40 g/day), vitamine B complex and folic acid (30 mg/day). When HCP patients also showed cutaneous symptoms, oral S-adenosyl-L-methionine (12 mg/kg/ day) for 3 weeks was given. Fil:Noriega, G. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Del Batlle, A.M.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03252787_v79_n3_p144_Stella
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic aminolevulinic acid
coproporphyrin
folic acid
fructose
glucose
porphobilinogen
porphyrin
s adenosylmethionine
vitamin b complex
adult
article
carbohydrate intake
clinical article
differential diagnosis
familial disease
female
human
hyperpigmentation
male
oral drug administration
photosensitivity
porphyria
porphyria cutanea tarda
porphyria variegata
relative
remission
spellingShingle aminolevulinic acid
coproporphyrin
folic acid
fructose
glucose
porphobilinogen
porphyrin
s adenosylmethionine
vitamin b complex
adult
article
carbohydrate intake
clinical article
differential diagnosis
familial disease
female
human
hyperpigmentation
male
oral drug administration
photosensitivity
porphyria
porphyria cutanea tarda
porphyria variegata
relative
remission
Stella, A.M.
Melito, V.E.
Melito, V.A.
Noriega, G.
Muramatsu, H.
Tomassi, L.
Magnin, P.H.
Del Batlle, A.M.C.
Coproporfiria hereditaria. Estudios bioquimicos en 7 pacientes sintomaticos y familiares
topic_facet aminolevulinic acid
coproporphyrin
folic acid
fructose
glucose
porphobilinogen
porphyrin
s adenosylmethionine
vitamin b complex
adult
article
carbohydrate intake
clinical article
differential diagnosis
familial disease
female
human
hyperpigmentation
male
oral drug administration
photosensitivity
porphyria
porphyria cutanea tarda
porphyria variegata
relative
remission
description Seven patients with hereditary coproporphyria (HCP) and 14 relatives from six families have been studied. Three of seven patients (43%) exhibited cutaneous signs, hyperpigmentation, photosensitivity and all of them presented acute neurovisceral attacks. Biochemical parameters of the HCP patients showed an increase of 5-aminolevulinic acid (ALA) (3.9 - 14.1 mg/24h.), porphobilinogen (PEG) (6.5 - 47.9 mg/24h) and total porphyrins (645 - 31129 μg/ 24h)in urine, which diminished when they reached remission (ALA: 0.2 - 5.3 mg/24hs; PBG: 0.8 -25.2 mg/24h, total porphyrins: 112 - 952 μg/24h, Normal Values: ALA: 2-4 mg/24h, PBG: 1-2 mg/ 24h, total porphyrins: 20 - 250 μg/24h). The fecal porphyrins were also increased during the acute phase (316 - 50,056 μg/g wet) and reduced in remission (165 -1600 μg/g wet). The pattern of urinary porphyrins showed a high concentration of coproporphyrin, and emission wavelengt at 618 nm of the plasma porphyrins allowed to distinguish this porphyria from variegate prophyria (VP). Treatment of the acute attack of HCP was similar to that applied to acute intermittent porphyria or VP: carbohydrates (acute attack: 330 - 500 g/day; light attacks: 20 - 40 g/day), vitamine B complex and folic acid (30 mg/day). When HCP patients also showed cutaneous symptoms, oral S-adenosyl-L-methionine (12 mg/kg/ day) for 3 weeks was given.
format JOUR
author Stella, A.M.
Melito, V.E.
Melito, V.A.
Noriega, G.
Muramatsu, H.
Tomassi, L.
Magnin, P.H.
Del Batlle, A.M.C.
author_facet Stella, A.M.
Melito, V.E.
Melito, V.A.
Noriega, G.
Muramatsu, H.
Tomassi, L.
Magnin, P.H.
Del Batlle, A.M.C.
author_sort Stella, A.M.
title Coproporfiria hereditaria. Estudios bioquimicos en 7 pacientes sintomaticos y familiares
title_short Coproporfiria hereditaria. Estudios bioquimicos en 7 pacientes sintomaticos y familiares
title_full Coproporfiria hereditaria. Estudios bioquimicos en 7 pacientes sintomaticos y familiares
title_fullStr Coproporfiria hereditaria. Estudios bioquimicos en 7 pacientes sintomaticos y familiares
title_full_unstemmed Coproporfiria hereditaria. Estudios bioquimicos en 7 pacientes sintomaticos y familiares
title_sort coproporfiria hereditaria. estudios bioquimicos en 7 pacientes sintomaticos y familiares
url http://hdl.handle.net/20.500.12110/paper_03252787_v79_n3_p144_Stella
work_keys_str_mv AT stellaam coproporfiriahereditariaestudiosbioquimicosen7pacientessintomaticosyfamiliares
AT melitove coproporfiriahereditariaestudiosbioquimicosen7pacientessintomaticosyfamiliares
AT melitova coproporfiriahereditariaestudiosbioquimicosen7pacientessintomaticosyfamiliares
AT noriegag coproporfiriahereditariaestudiosbioquimicosen7pacientessintomaticosyfamiliares
AT muramatsuh coproporfiriahereditariaestudiosbioquimicosen7pacientessintomaticosyfamiliares
AT tomassil coproporfiriahereditariaestudiosbioquimicosen7pacientessintomaticosyfamiliares
AT magninph coproporfiriahereditariaestudiosbioquimicosen7pacientessintomaticosyfamiliares
AT delbatlleamc coproporfiriahereditariaestudiosbioquimicosen7pacientessintomaticosyfamiliares
_version_ 1807315336233484288